What is the FDA warning on rituximab? A Comprehensive Look at Safety Risks
•
4 min read
The FDA has issued multiple serious, or 'boxed', warnings for rituximab due to significant adverse event reports. The most important safety information includes risks of fatal infusion reactions, progressive multifocal leukoencephalopathy (PML), and hepatitis B virus (HBV) reactivation.
